AN
50
-5
COST
56
3
HCP
64
-2
TRV
64
2
DIS
60
2
UNP
40
-2
MOS
19
-4
SO
66
2
CMS
67
3
ROK
44
-7
MSI
72
2
NWSA
47
-2
ALL
61
-2
IPG
39
-3
SWK
81
-3
PLD
51
-5
SCHW
52
3
UPS
55
-6
SLB
53
-3
TRIP
66
5
AN
50
-5
COST
56
3
HCP
64
-2
TRV
64
2
DIS
60
2
UNP
40
-2
MOS
19
-4
SO
66
2
CMS
67
3
ROK
44
-7
MSI
72
2
NWSA
47
-2
ALL
61
-2
IPG
39
-3
SWK
81
-3
PLD
51
-5
SCHW
52
3
UPS
55
-6
SLB
53
-3
TRIP
66
5
Financhill
Back

Allient Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
33

ALNT
Allient

Last Price:
20.29
Seasonality Move:
1.29%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
33
Allient (ALNT) is a Sell

Is Allient a Buy, Sell or Hold?

  • The current Allient [ALNT] share price is $20.26. The Score for ALNT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ALNT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ALNT Stock Price Chart

What is Allient's stock price today?

  • The Allient share price today is $20.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ALNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 43.79 Sell
Chaikin Money Flow: -151368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.67 - 21.17) Sell
Bollinger Bands (100): (21.55 - 28.45) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ALNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.15 Buy
20-day SMA: 20.31 Sell
50-day SMA: 23.09 Sell
200-day SMA: 27.56 Sell
8-day EMA: 20.29 Sell
20-day EMA: 20.56 Sell
50-day EMA: 22.27 Sell
200-day EMA: 26.73 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Allient Earnings Growth & ALNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.43 per share, a decrease this year of $0.71 per share, and an increase next year of $0.47 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Allient Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):